The analysis of the relationship between sarcopenia and irisin serum levels among subjects with more advanced cancer remained outside of our investigation, although, in the past decade, some papers established the prognostic role of sarcopenia in cirrhotic patients who underwent systemic therapy for hepatocellular carcinoma [43,44]. The gene discussed is FNDC5; the disease is hepatocellular carcinoma.